.png)

Runner-up
2015
Think Big
Challenge
Reveal Biosensors
Introduces the first Cellular Energy Monitor
Reveal Biosensors is developing a new generation of physiologic sensing technology designed to expand what clinicians, care platforms, and healthcare innovators can see about the human body's response to oxygen and physiologic stress.
At the core of our platform is the Reveal Cellular Energy Monitor, a novel light-based sensing technology that measures cellular responses and adaptation to changes in oxygen supply in real time. This technology generates a new category of physiologic biomarkers, including the Cellular Energy Index (CEi), providing insights that extend beyond traditional measurements such as heart rate and blood oxygen.
For decades, healthcare has relied on vital signs that often detect deterioration only after significant deterioration has already occurred. Reveal's mission is to provide a next generation physiologic sensing layer for clinical monitoring to enable potentially breakthrough new acute care applications. Our technology is being evaluated across a range of clinical applications where oxygen utilization and physiologic adaptation are critically important, including perioperative care, respiratory monitoring, neonatal medicine, remote patient monitoring, value-based care, and emerging AI-enabled healthcare platforms.
Research conducted in collaboration with leading academic medical centers has demonstrated the ability of Reveal's sensing platform to detect critically important physiologic responses associated with oxygen exposure that are not visible by blood gas measurements or pulse oximetry. These new findings suggest the potential to expand clinical awareness of both inadequate and excessive oxygen exposure.
Reveal's platform is designed as a complementary enhancement to existing monitoring systems, rather than as a replacement. By integrating seamlessly into established medical devices, workflows, and digital health platforms, Reveal aims to provide clinicians and healthcare organizations with a broader and higher-resolution view of patient physiology, while preserving the simplicity and familiarity of current monitoring practices.
As healthcare increasingly embraces remote monitoring, artificial intelligence, and value-based care models, the need for continuous, reliable, and relevant physiologic insight is becoming more important than ever. We believe needed improvements in healthcare will require more complete and relevant physiologic data implemented by better workflows and algorithms.
Reveal Biosensors is actively seeking strategic partnerships with medical device manufacturers, digital health companies, remote monitoring providers, healthcare platforms, and consumer health innovators. Through licensing and collaborative development relationships, we aim to accelerate adoption of this new physiologic sensing capability across both regulated and consumer markets.
Our vision is simple:
To become the advanced physiology sensing layer that helps clinicians, healthcare systems, and AI-enabled care platforms recognize physiologic change earlier, more effectively personalize care, and improve patient outcomes across the continuum of care.